Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00225823
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2005-09-22
Brief Title:
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomised Double-Blind Placebo-Controlled Parallel Group Multicentre Two Week Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis in Europe
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure The focus of this study seasonal allergic rhinitis SAR is one type of allergic rhinitis that is triggered by the pollen from trees grasses and weeds Commonly referred to as hay fever it is characterized by sneezing nasal congestion and pruritus rhinorrhea and pruritic watery red eyes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None